PL1885382T3 - Sposoby stosowania komórek pochodzących z tkanki tłuszczowej w leczeniu stanów układu sercowo-naczyniowego - Google Patents
Sposoby stosowania komórek pochodzących z tkanki tłuszczowej w leczeniu stanów układu sercowo-naczyniowegoInfo
- Publication number
- PL1885382T3 PL1885382T3 PL05754073T PL05754073T PL1885382T3 PL 1885382 T3 PL1885382 T3 PL 1885382T3 PL 05754073 T PL05754073 T PL 05754073T PL 05754073 T PL05754073 T PL 05754073T PL 1885382 T3 PL1885382 T3 PL 1885382T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- adipose tissue
- cells
- cardiovascular conditions
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05754073A EP1885382B1 (en) | 2005-05-25 | 2005-05-25 | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
PCT/US2005/018605 WO2006127007A2 (en) | 2005-05-25 | 2005-05-25 | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1885382T3 true PL1885382T3 (pl) | 2011-09-30 |
Family
ID=37452485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05754073T PL1885382T3 (pl) | 2005-05-25 | 2005-05-25 | Sposoby stosowania komórek pochodzących z tkanki tłuszczowej w leczeniu stanów układu sercowo-naczyniowego |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP1885382B1 (pl) |
JP (1) | JP5210155B2 (pl) |
KR (2) | KR101278437B1 (pl) |
CN (1) | CN101443023A (pl) |
AT (1) | ATE500319T1 (pl) |
AU (1) | AU2005332046B2 (pl) |
CA (1) | CA2609361C (pl) |
DE (1) | DE602005026724D1 (pl) |
DK (1) | DK1885382T3 (pl) |
ES (1) | ES2364689T3 (pl) |
PL (1) | PL1885382T3 (pl) |
WO (1) | WO2006127007A2 (pl) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
CN1630526B (zh) | 2001-12-07 | 2010-05-05 | 马克罗珀尔生物外科公司 | 用加工的脂肪抽吸细胞来治疗患者的系统和方法 |
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US7794449B2 (en) | 2005-03-23 | 2010-09-14 | Shippert Ronald D | Tissue transplantation method and apparatus |
US9581942B1 (en) | 2005-03-23 | 2017-02-28 | Shippert Enterprises, Llc | Tissue transfer method and apparatus |
US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
US7789872B2 (en) | 2005-03-23 | 2010-09-07 | Shippert Ronald D | Tissue transplantation method and apparatus |
US8062286B2 (en) | 2005-03-23 | 2011-11-22 | Shippert Ronald D | Tissue transplantation method and apparatus |
US7780649B2 (en) | 2005-03-23 | 2010-08-24 | Shippert Ronald D | Tissue transplantation method and apparatus |
ES2325715B1 (es) | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
KR101679671B1 (ko) * | 2009-10-27 | 2016-11-28 | 도병록 | 재생성 세포 추출 시스템 |
US8887770B1 (en) | 2011-03-17 | 2014-11-18 | Ronald D. Shippert | Vessel fill control method and apparatus |
CN102151153A (zh) * | 2011-03-25 | 2011-08-17 | 吴成翰 | 外科手术过程中组织碎片的回收装置 |
JP5628131B2 (ja) * | 2011-10-19 | 2014-11-19 | サイトリ セラピューティクス インコーポレイテッド | 心血管状態の治療において脂肪組織由来細胞を使用する方法 |
EP2677024B1 (de) * | 2012-06-22 | 2019-11-20 | Human Med AG | Vorrichtung zum Separieren von adulten Stammzellen |
US9259435B2 (en) * | 2012-08-31 | 2016-02-16 | W. L. Gore & Associates, Inc. | Reactive oxidative species generating materials and methods of use |
US9468709B2 (en) | 2012-11-12 | 2016-10-18 | Shippert Enterprises, Llc | Syringe fill method and apparatus |
US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
US20160361476A1 (en) * | 2014-02-28 | 2016-12-15 | Bdbc Sciences Corp. | System for tissue manipulation |
US10772997B2 (en) | 2014-05-15 | 2020-09-15 | Ronald D. Shippert | Tissue parcelization method and apparatus |
DE102015109148B3 (de) * | 2015-06-10 | 2016-05-04 | Human Med Ag | Vorrichtung zum Separieren von regenerativen und adulten Stammzellen |
CN106318905A (zh) * | 2015-07-10 | 2017-01-11 | 中国科学院上海生命科学研究院 | 血栓烷素a2受体作为脂肪干细胞治疗缺血性疾病的靶标 |
JP6854519B2 (ja) * | 2016-01-19 | 2021-04-07 | 国立大学法人大阪大学 | 心疾患の治療のための移植材料 |
US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
KR102579835B1 (ko) | 2016-06-08 | 2023-09-15 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 조직 및 세포를 프로세싱하기 위한 방법 및 장치 |
JP6256786B1 (ja) * | 2017-04-12 | 2018-01-10 | 学校法人福岡大学 | 不妊症の処置に用いられる医薬組成物およびその製造方法 |
CN107988151A (zh) * | 2017-12-06 | 2018-05-04 | 北京大学第三医院 | 一种体外诱导带血管蒂的脂肪组织成肌方法 |
US20230063104A1 (en) * | 2020-02-04 | 2023-03-02 | Hierabio Inc | Composition for intrapericardial injection comprising stem cells and use thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US482820A (en) | 1892-09-20 | Ernest p | ||
US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
FR2742662B1 (fr) | 1995-12-21 | 1998-01-23 | Centre Nat Rech Scient | Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments |
US6280473B1 (en) | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US5919234A (en) | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
CA2296704C (en) * | 1997-07-14 | 2010-10-19 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
US6269716B1 (en) | 1998-11-18 | 2001-08-07 | Macropore, Inc. | High-torque resorbable screws |
CA2327789C (en) | 1998-04-07 | 2007-09-04 | Macropore, Inc. | Membrane with tissue-guiding surface corrugations |
US6001642A (en) | 1998-06-29 | 1999-12-14 | Wyle Laboratories, Inc. Life Sciences | Bioreactor and cell culturing processes using the bioreactor |
US6653146B1 (en) | 1999-11-15 | 2003-11-25 | Chemclean Corporation | Bio-burden visualization system |
US6531146B2 (en) | 2000-03-10 | 2003-03-11 | Macropore, Inc. | Resorbable barrier micro-membranes for attenuation of scar tissue during healing |
US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
WO2002028472A2 (en) | 2000-10-04 | 2002-04-11 | James Peter Amis | Non-scatterable, radio-opaque marker for medical imaging applications |
FR2819265B1 (fr) * | 2001-01-10 | 2004-01-02 | Centre Nat Rech Scient | Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution des lignees hematopoietiques |
EP1379869A4 (en) * | 2001-03-15 | 2004-08-11 | Xiao Yong Fu | METHOD FOR THERAPEUTICALLY TREATING A CLINICALLY DETECTED CARDIOPATHOLOGICAL FORM IN A MAMMAL |
US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
CN1630526B (zh) * | 2001-12-07 | 2010-05-05 | 马克罗珀尔生物外科公司 | 用加工的脂肪抽吸细胞来治疗患者的系统和方法 |
JP2004099471A (ja) * | 2002-09-05 | 2004-04-02 | Cardio Corp | 心筋梗塞および心不全の治療薬 |
ES2373551T3 (es) * | 2003-02-20 | 2012-02-06 | Cytori Therapeutics, Inc. | Métodos para usar células derivadas de tejido adiposo en el tratamiento de afecciones cardiovasculares. |
EP1648999A4 (en) * | 2003-06-25 | 2006-09-06 | Macropore Biosurgery Inc | SYSTEMS AND METHOD FOR SEPARATING AND ENRICHING REGENERATIVE CELLS FROM TISSUE |
WO2005034843A2 (en) * | 2003-09-17 | 2005-04-21 | Macropore Biosurgery Inc. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
CA2550961A1 (en) * | 2003-12-25 | 2005-07-14 | Kanazawa University Technology Licensing Organization Ltd. | Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
-
2005
- 2005-05-25 DK DK05754073.4T patent/DK1885382T3/da active
- 2005-05-25 EP EP05754073A patent/EP1885382B1/en not_active Not-in-force
- 2005-05-25 KR KR1020077030170A patent/KR101278437B1/ko active IP Right Grant
- 2005-05-25 ES ES05754073T patent/ES2364689T3/es active Active
- 2005-05-25 PL PL05754073T patent/PL1885382T3/pl unknown
- 2005-05-25 WO PCT/US2005/018605 patent/WO2006127007A2/en active Application Filing
- 2005-05-25 DE DE602005026724T patent/DE602005026724D1/de active Active
- 2005-05-25 AU AU2005332046A patent/AU2005332046B2/en not_active Ceased
- 2005-05-25 JP JP2008513441A patent/JP5210155B2/ja active Active
- 2005-05-25 CA CA2609361A patent/CA2609361C/en not_active Expired - Fee Related
- 2005-05-25 AT AT05754073T patent/ATE500319T1/de not_active IP Right Cessation
- 2005-05-25 CN CNA2005800502651A patent/CN101443023A/zh active Pending
- 2005-05-25 KR KR1020137005581A patent/KR101400544B1/ko active IP Right Grant
- 2005-05-25 EP EP11152868.3A patent/EP2465923B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
EP2465923B1 (en) | 2018-04-11 |
CN101443023A (zh) | 2009-05-27 |
EP1885382B1 (en) | 2011-03-02 |
JP2008545687A (ja) | 2008-12-18 |
KR20130038412A (ko) | 2013-04-17 |
JP5210155B2 (ja) | 2013-06-12 |
EP1885382A2 (en) | 2008-02-13 |
EP2465923A2 (en) | 2012-06-20 |
KR101400544B1 (ko) | 2014-05-27 |
ES2364689T3 (es) | 2011-09-12 |
KR20080017389A (ko) | 2008-02-26 |
EP2465923A3 (en) | 2012-06-27 |
KR101278437B1 (ko) | 2013-06-25 |
AU2005332046B2 (en) | 2013-05-16 |
AU2005332046A1 (en) | 2006-11-30 |
WO2006127007A2 (en) | 2006-11-30 |
DK1885382T3 (da) | 2011-06-20 |
WO2006127007A3 (en) | 2009-04-16 |
ATE500319T1 (de) | 2011-03-15 |
CA2609361C (en) | 2017-11-14 |
EP1885382A4 (en) | 2009-09-09 |
DE602005026724D1 (de) | 2011-04-14 |
CA2609361A1 (en) | 2006-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1885382T3 (pl) | Sposoby stosowania komórek pochodzących z tkanki tłuszczowej w leczeniu stanów układu sercowo-naczyniowego | |
HK1102085A1 (en) | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions | |
WO2005034843A3 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
WO2006014159A3 (en) | Methods of using regenerative cells in the treatment of musculoskeletal disorders | |
AU2009100401A4 (en) | Method of extracting and activating adipose-derived stem cells | |
EP2305276A3 (en) | Processed lipoaspirate cells for use in therapy | |
PL1778833T3 (pl) | Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran | |
MX2010003548A (es) | Metodos para el tratamiento de padecimientos neurologicos autoinmunes con ciclofosfamida. | |
AR109103A1 (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert | |
MX2009012197A (es) | Metodos para tratamiento de ulceras en la piel. | |
MX365007B (es) | Uso de acido lipasa lisosomal para tratar la dificiencia de acido lipasa lisosomal en pacientes. | |
EP2608797A4 (en) | CD271 PRECURSOR CELLS FROM BONE MARROW FOR CARDIAC REPAIR | |
WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
MX2009007247A (es) | Metodo para el tratamiento de afecciones asociadas con actividad aumentada de 5-lipoxigenasa y/o leucotrienos. | |
WO2006014162A3 (en) | Methods of using regenerative cells in the treatment of renal diseases and disorders | |
GB0405381D0 (en) | A method and means for treating heart failure | |
WO2008027238A3 (en) | Induction of immunosuppression by inhibition of atm | |
MX2022015109A (es) | Tratamiento de homocistinuria e hiperhomocisteinemia mediante el uso de cistationina-gamma-liasa. | |
MX2011011114A (es) | Materiales y metodos para utilizar celulas madre de tejido adiposo para tratar una lesion y enfermedad pulmonar. | |
UA6522U (en) | Method for treating patients with multiple and combined injuries of long bones | |
RU2008142658A (ru) | Способ лечения инфекционных поражений нервной системы | |
WO2009057461A1 (ja) | 糖尿病治療剤 | |
UA37078U (ru) | Способ профилактики рефлюкс-холангита при хирургическом лечении больных с механической желтухой |